Detalles de la búsqueda
1.
Atypical age distribution and high disease severity in children with RSV infections during two irregular epidemic seasons throughout the COVID-19 pandemic, Germany, 2021 to 2023.
Euro Surveill;
29(13)2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38551098
2.
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022.
Euro Surveill;
29(13)2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38551095
3.
Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024.
Euro Surveill;
29(8)2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38390651
4.
Unmasking a silent killer: Prevalence of diagnosed and undiagnosed diabetes mellitus among people living with HIV in rural South Africa.
Trop Med Int Health;
28(5): 367-373, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36920286
5.
[Monitoring of COVID-19 by extending existing surveillance for acute respiratory infections]. / Überwachung von COVID-19 durch Erweiterung der etablierten Surveillance für Atemwegsinfektionen.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz;
64(4): 395-402, 2021 Apr.
Artículo
en Alemán
| MEDLINE | ID: mdl-33760935
6.
Exploring the effect of clinical case definitions on influenza vaccine effectiveness estimation at primary care level: Results from the end-of-season 2022-23 VEBIS multicentre study in Europe.
Vaccine;
42(16): 3547-3554, 2024 Jun 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38704257
7.
Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023-January 2024.
Vaccine;
2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38839521
8.
Influenza vaccine effectiveness in Europe: Results from the 2022-2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study.
Influenza Other Respir Viruses;
18(1): e13243, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38204584
9.
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021-2022 I-MOVE primary care multicentre study.
Influenza Other Respir Viruses;
17(1): e13069, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36702797
Resultados
1 -
9
de 9
1
Próxima >
>>